Skip to main content

Advertisement

SpringerLink
Log in

Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Objective

To evaluate changes in neural retina (NR) thickness and best-corrected visual acuity (BCVA) induced by treatment of chronic central serous chorioretinopathy (CSC) by photodynamic therapy (PDT).

Patients and methods

Retrospective study of 25 eyes of 25 patients with chronic CSC treated by “full-fluence” PDT. LogMAR BCVA and Stratus optical coherence tomography (OCT) were evaluated before treatment and 1 year after PDT. Twenty-four eyes from 24 patients with non-chronic, non-PDT-treated forms of CSC were evaluated as a control group.

Results

NR foveal thickness before PDT was 182 ± 43.4 μm (range, 92–246) vs 148.1 ± 30.9 μm (range, 101–220) 1 year after treatment (p = 0.004; Student's t-test paired data). NR foveal thickness in the untreated eyes was 204.6 ± 30.7 μ (range, 132–249) vs 192.5 ± 26.4 μ (range, 123–235) after self-resolution (p = 0.03; Student's t-test paired data). Basal NR thickness was statistically significant different between both groups (p = 0.04; Student's t-test); this difference continued to be significant at the end of the follow-up (p < 0.01; Student's t-test). All the patients with chronic CSC treated by PDT showed anatomic resolution, and BCVA improved from 0.38 ± 0.35 to 0.23 ± 0.29 (p = 0.007; Student's t-test paired data). Final BCVA and basal and final NR thickness showed poor correlation (Pearson = 0.2 and 0.1 respectively).

Conclusions

The use of PDT in chronic CSC induces NR thickness thinning. This change is not correlated with a decrease in BCVA. Spontaneous resolution of classic CCS also showed significant NR thinning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Leaver P, Williams C (1979) Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 63:674–677

    Article  PubMed  CAS  Google Scholar 

  2. Robertson DM, Ilstrup D (1983) Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 95:457–466

    PubMed  CAS  Google Scholar 

  3. Gilbert CM, Owens SL, Smith PD, Fine SL (1984) Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 68:815–820

    Article  PubMed  CAS  Google Scholar 

  4. Ficker L, Vafidis G, While A, Leaver P (1988) Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72:829–834

    Article  PubMed  CAS  Google Scholar 

  5. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K (1992) Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 2:103–114

    PubMed  CAS  Google Scholar 

  6. Piccolino FC, Borgia L, Zinicola E, Zingirian M (1995) Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 9:324–332

    Article  PubMed  Google Scholar 

  7. Prünte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26–34

    PubMed  Google Scholar 

  8. Parodi MB, Pozzo SD, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235–237

    Article  Google Scholar 

  9. Canakis C, Livir-Rallatos C, Panayiotis Z, Livir-Rallatos G, Persidis E, Conway MD, Peyman GA (2003) Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 136:750–752

    Article  PubMed  Google Scholar 

  10. Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073–1080

    Article  PubMed  Google Scholar 

  11. Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM, Angelilli A, Eandi CM, Lyon AT (2005) Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 112:2088–2094

    Article  PubMed  Google Scholar 

  12. Valmaggia C, Niederberger H (2006) Photodynamic therapy in the treatment of chronic central serous chorioretinopathy. Klin Monatsbl Augenheilkd 223:372–375

    Article  PubMed  CAS  Google Scholar 

  13. Tarantola RM, Law JC, Recchia FM, Sternberg P Jr, Agarwal A (2008) Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. Lasers Surg Med 40:671–675

    Article  PubMed  Google Scholar 

  14. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298

    Article  PubMed  Google Scholar 

  15. Piccolino CF, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763

    Article  Google Scholar 

  16. Moon JW, Yu HG, Kim TW, Kim HC, Chung H (2009) Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247:1315–1323

    Article  PubMed  CAS  Google Scholar 

  17. Ruiz-Moreno JM, Lugo FL, Armadá F, Silva R, Montero JA, Arevalo JF, Arias L, Gómez-Ulla F (2010) Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmol 88:371–376

    PubMed  Google Scholar 

  18. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915–1923

    Article  PubMed  CAS  Google Scholar 

  19. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799

    Article  PubMed  Google Scholar 

  20. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H (2002) Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 43:830–841

    PubMed  Google Scholar 

  21. Schmidt-Erfuth U, Laqua H, Schlötzer-Schrehardt U, Vistenz A, Naumann GOH (2002) Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120:835–844

    Google Scholar 

  22. Bressler NM (2001) Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2:198–207

    Google Scholar 

  23. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. – Verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541–560

    Article  Google Scholar 

  24. Fine SL, Patz A, Orth DH, Klein ML, Finkelstein D, Yassur Y (1976) Subretinal neovascularization developing after prophylactic argon laser photocoagulation of atrophic macular scars. Am J Ophthalmol 82:352–357

    PubMed  CAS  Google Scholar 

  25. Varley MP, Frank E, Purnell EW (1988) Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology 95:567–573

    PubMed  CAS  Google Scholar 

  26. Lewis H, Schachat AP, Haimann MH, Haller JA, Quinlan P, von Fricken MA, Fine SL, Murphy RP (1990) Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 97:503–510

    PubMed  CAS  Google Scholar 

  27. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90:869–874

    Article  PubMed  CAS  Google Scholar 

  28. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93

    Article  PubMed  Google Scholar 

  29. Shin JY, Woo SJ, Yu HG, Park KH (2010) Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina 31:119–126

    Article  Google Scholar 

  30. Koytak A, Erol K, Coskun E, Asik N, Oztürk H, Ozertürk Y (2010) Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy. Retina 30:1698–1703

    Article  PubMed  Google Scholar 

  31. Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133:787–793

    Article  PubMed  Google Scholar 

  32. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 40:2322–2331

    PubMed  CAS  Google Scholar 

  33. Schlötzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U (2002) Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 240:748–757

    Article  PubMed  Google Scholar 

  34. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458

    Article  PubMed  Google Scholar 

  35. Forte R, Cennamo GL, Finelli ML, de Crecchio G (2009) Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye 23:2071–2078

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Castilla La Mancha University, Albacete, Spain

    Sergio Copete, Jose M. Ruiz-Moreno & Carlos Cava

  2. Alicante Institute of Ophthalmology VISSUM, Alicante, Spain

    Jose M. Ruiz-Moreno & Javier A. Montero

  3. Pio Rio Hortega University Hospital, Valladolid, Spain

    Javier A. Montero

  4. Departamento de Ciencias Médicas, Facultad de Medicina, Avda de Almansa, 14, 02006, Albacete, Spain

    Sergio Copete

Authors
  1. Sergio Copete
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose M. Ruiz-Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos Cava
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Javier A. Montero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergio Copete.

Additional information

This study has been supported in part by a grant of the Spanish Ministry of Health, Instituto de Salud Carlos III, Red Temática de Investigación Cooperativa en Salud "Patología ocular del envejecimiento, calidad visual y calidad de vida" (RD 07/0062/0019). None of the authors has any financial interests to disclose

Rights and permissions

Reprints and permissions

About this article

Cite this article

Copete, S., Ruiz-Moreno, J.M., Cava, C. et al. Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 250, 803–808 (2012). https://doi.org/10.1007/s00417-011-1900-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-011-1900-9

Keywords

Search

Navigation